Environment
-
First-of-its-kind AstraZeneca Drug Cuts Risk of Severe COVID-19 by 50%
AstraZeneca company announced on Monday the results of its Phase III COVID-19 treatment trial which showed that their antibody drug is the first of its kind to both prevent and treat COVID-19, and cut the risk of severe COVID-19 by at least 50 percent.
Latest Research Articles
-
Australian Teenagers Arrested for Brutally Slaughtering 14 Kangaroos, Including 2 Joeys
Metal-Eating Bacteria Can Consume a Nail in Three Days: Can it Help Clean up Mine Sites?
-
Tropical Storm in the Philippines Leaves 13 People Dead and 9 Missing
-
Cancer Drug Derived From Himalayan 'Caterpillar Fungus' Smashes Early Clinical Trial
-
6 Million Children Driven to Hunger Due to Severe Drought Brought by El Nino
-
California Firefighters Battle Alisal Fire as Strong Winds Worsens the Situation
-
Spanish Pig Farms are Being Blamed for the Mass Fish Death in Europe, Here's Why
-
Experts Debunked Fears of Mega-Tsunami Coming to East Coast Due to La Palma Volcanic Eruption
-
Operation Ocean Cleanup Just Scooped Massive Pile of Garbage in Great Pacific
Scientists Exploring Shipwreck Discover Mysterious 'Larger Than Human' Deep-Sea Creature
-
NHC Raises Flash Flood Alerts in Texas as Potentially Deadly Hurricane Pamela Draws Closer
8 Million People May Lose Access to Clean Water as Rotting Ship Worsens Oil Spill in Red Sea
MOST POPULAR
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Meet The Dire Wolf Trio Remus, Romulus And Khaleesi: How A Texas Lab Revived An Extinct Species
-
Massive New Jersey Wildfire Devastates 8,500 Acres, Threatens Wildlife and Communities Amid Historic Drought
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
